The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trial in progress: Natural killer (NK) cells with TGFβ receptor I inhibitor vactosertib and IL-2 in patients with metastatic colorectal cancer or hematologic malignancies.
 
J. Eva Selfridge
Research Funding - BioAtla (Inst); Cue Biopharma (Inst); Pfizer (Inst); Trishula Therapeutics (Inst); Vigeo Therapeutics (Inst)
 
David L Bajor
Consulting or Advisory Role - Avoro Capital Advisors; BridgeBio Pharma; Cardinal Health; Tempus
Speakers' Bureau - Natera
Research Funding - Abbvie; Apexigen (Inst); Bristol-Myers Squibb/Celgene (Inst); Calithera Biosciences (Inst); GlaxoSmithKline (Inst); Rafael Pharmaceuticals (Inst); Seagen (Inst); Tesaro (Inst)
 
AMR MOHAMED
Research Funding - HUTCHMED; Novatek; RayzeBio
 
Sakti Chakrabarti
Honoraria - Natera
Speakers' Bureau - Natera
 
Jane Reese
No Relationships to Disclose
 
Hillard M. Lazarus
Employment - Case Western Reserve University; Partner Therapeutics
Stock and Other Ownership Interests - Partner Therapeutics
Honoraria - Actinium Pharmaceuticals; AstraZeneca; biosight; Bristol-Myers Squibb; Celgene; CSL Behring; Jazz Pharmaceuticals; Pluristem Therapeutics; Seagen
Consulting or Advisory Role - Actinium Pharmaceuticals; biosight; Bristol-Myers Squibb/Medarex; Celgene; CSL Behring; Jazz Pharmaceuticals; Pluristem Therapeutics; Seagen
Speakers' Bureau - AstraZeneca; Jazz Pharmaceuticals; Seagen
Travel, Accommodations, Expenses - Actinium Pharmaceuticals; AstraZeneca; biosight; Jazz Pharmaceuticals; Seagen
 
Afshin Dowlati
Consulting or Advisory Role - Abbvie/Stemcentrx; AstraZeneca; Bayer; Bristol-Myers Squibb; G1 Therapeutics; Ipsen; Merck; Takeda
Research Funding - Abbvie/Stemcentrx (Inst); Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Ipsen (Inst); Lilly/ImClone (Inst); Mirati Therapeutics (Inst); Regeneron (Inst); Seagen (Inst); Symphogen (Inst); Takeda (Inst); Tesaro (Inst); United Therapeutics (Inst)
 
Amit Mahipal
Consulting or Advisory Role - AstraZeneca/MedImmune; QED Therapeutics; Taiho Oncology
Speakers' Bureau - AstraZeneca
Research Funding - Taiho Pharmaceutical
 
David Wald
Stock and Other Ownership Interests - Kure.ai
Honoraria - One Lambda
Research Funding - Bristol Myers Squibb Foundation; Karyopharm Therapeutics
Patents, Royalties, Other Intellectual Property - Inventor on patent applications related to NK cell therapy